" class="no-js "lang="en-US"> News Archives - Page 144 of 267 - Medtech Alert
Monday, June 15, 2026

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

New Clinical Trials Deal Struck to Better Protect World From Future Pandemics

Millions of people across the world will be better protected from future pandemics thanks to […]

Medtronic and DaVita Announce New Kidney Health Technology Company

Medtronic plc (NYSE:MDT) and DaVita Inc. (NYSE:DVA) today announced the intent to form a new, independent kidney care-focused […]

PharmEnable Announces Multi-target Collaboration With Denali Therapeutics in Neurodegenerative Disease

PharmEnable, an AI drug-discovery company mapping unexplored chemical space to deliver innovative medicines, has announced […]

Next-Generation Immunotherapy Drug Shows Continued Promise in Several Advanced-Stage Cancers

Initial study results show that an experimental drug, called nemvaleukin alfa, when used alone or […]

Bio-Rad Launches CFX Duet Real-Time PCR System

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and […]

Roche’s Polivy Combination Approved by European Commission for People With Previously Untreated Diffuse Large B-cell Lymphoma

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission (EC) has granted […]

Medical Microinstruments Launches New Simulator for Robotic Microsurgery

Medical Microinstruments (MMI) SpA, a robotics company dedicated to improving clinical outcomes for patients undergoing […]

Novavax Announces Participation in Oxford University Com-COV3 Booster Trial of COVID-19 Vaccines in Adolescents Aged 12 Through

Novavax is participating in a stage of the COVID-19 Vaccine Schedule Combinations (Com-COV) program initiated by the […]

Roche Develops Unique PCR Tests to Detect the Monkeypox Virus

Roche (SIX: RO, ROG; OTCQX: RHHBY) and its subsidiary TIB Molbiol have developed three unique LightMix® Modular Virus […]

NuvoAir Launches Remote Asthma Service to Support NHS with Faster Diagnosis and Treatment

NuvoAir’s Asthma Assessment Service uses respiratory physiologists and connected, award-winning home monitoring technology, such as […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more